The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
The Lancet3d
Rising diabetes, lagging treatment, and the need for better systems
The study is the first set of global estimates directly linking diabetes prevalence with treatment coverage over a ...